John A Stalfort Iii Acumen Pharmaceuticals, Inc. (ABOS) insider trading activity

John A Stalfort Iii is Director of Acumen Pharmaceuticals, Inc.. Currently has a direct ownership of 172,324 shares of ABOS, which is worth approximately $306,736. The most recent transaction as insider was on Jul 06, 2021, when has been sold 35,000 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $560,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 172K

0% 3M change

0% 12M change

Total Value Held $306,736

John A Stalfort III Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jul 06 2021	BUY Open market or private purchase	$560,000 $16.0 p/Share	35,000 Added 16.88%	172,324 Common Stock
Jul 06 2021	BUY Conversion of derivative security	-	130,180 Added 48.66%	137,324 Common Stock

Also insider at

VRCA

Verrica Pharmaceuticals Inc. Healthcare

TSHA

Taysha Gene Therapies, Inc. Healthcare

JAS